← Peptide Library
Research GradeWeight Management & Metabolic
Tesamorelin
5 mg
Stabilized GHRH analogue for visceral adiposity research.
Overview
Tesamorelin is a 44-amino-acid GHRH analogue with N-terminal trans-3-hexenoic acid modification studied for visceral adipose tissue research.
Mechanism of Action
Binds pituitary GHRH receptors, restoring physiologic pulsatile GH/IGF-1 secretion and influencing lipolytic pathways in visceral fat depots.
Research Findings
Tesamorelin in HIV-Associated Lipodystrophy
NEJM, 2007
Visceral adipose tissue reduction in study cohorts.
Potential Research Applications
- Lipid metabolism research
- GHRH receptor studies